评估肿瘤生物标志物与儿童癌症的关系

Şule ÇALIŞKAN KAMIŞ , Metin ÇİL , Begül YAĞCI KÜPELİ
{"title":"评估肿瘤生物标志物与儿童癌症的关系","authors":"Şule ÇALIŞKAN KAMIŞ ,&nbsp;Metin ÇİL ,&nbsp;Begül YAĞCI KÜPELİ","doi":"10.1016/j.htct.2024.04.043","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>We aimed to investigate the indications for Carbohydrate antigen 19-9 (CA 19-9), carbohydrate antigen 125 (CA-125), carbohydrate antigen 15-3 (CA15-3) and carcinoembryogenic antigen (CEA) tumor biomarkers, less commonly used in children, and their association with patients diagnosed with childhood cancers.</p></div><div><h3>Methodology</h3><p>The study aimed to include patients aged 0-18 who had CA 19-9, CA-125, CA 15-3 and CEA tumor biomarker assessments at Adana City Training and Research Hospital (ACTRH) between 01.11.2022 and 01.11.2023. CA 19-9, CA-125, CA 15-3 and CEA values were recorded from routinely collected serum/blood samples of the patients. The relationship between tumor biomarkers and patients diagnosed with childhood cancers was evaluated.</p></div><div><h3>Results</h3><p>The study included 211 patients. Out of 211 patients, 145 (68.7%) were female, and 66 (31.3%) were male. Malignancy was detected in 35 patients (16.6%). There was no statistically significant relationship observed between CA 15-3, CA 19-9, and CEA positivity and the detection of malignancy. The respective p-values were found to be (p=0.711, p= 0.533, p=0.573). A statistically significant relationship was observed between CA-125 positivity and the detection of malignancy (p=0.002).</p></div><div><h3>Conclusion</h3><p>Tumor markers alone are not sufficient for making a definitive diagnosis or determining treatment decisions. However further comprehensive studies are needed for detection of association conventional tumor markers and childhood cancers.</p></div>","PeriodicalId":12958,"journal":{"name":"Hematology, Transfusion and Cell Therapy","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531137924001251/pdfft?md5=78cb5f38388d222e37665dba01ff65ef&pid=1-s2.0-S2531137924001251-main.pdf","citationCount":"0","resultStr":"{\"title\":\"EVALUATION OF THE ASSOCIATION OF TUMOR BIOMARKERS WITH CHILDHOOD CANCERS\",\"authors\":\"Şule ÇALIŞKAN KAMIŞ ,&nbsp;Metin ÇİL ,&nbsp;Begül YAĞCI KÜPELİ\",\"doi\":\"10.1016/j.htct.2024.04.043\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>We aimed to investigate the indications for Carbohydrate antigen 19-9 (CA 19-9), carbohydrate antigen 125 (CA-125), carbohydrate antigen 15-3 (CA15-3) and carcinoembryogenic antigen (CEA) tumor biomarkers, less commonly used in children, and their association with patients diagnosed with childhood cancers.</p></div><div><h3>Methodology</h3><p>The study aimed to include patients aged 0-18 who had CA 19-9, CA-125, CA 15-3 and CEA tumor biomarker assessments at Adana City Training and Research Hospital (ACTRH) between 01.11.2022 and 01.11.2023. CA 19-9, CA-125, CA 15-3 and CEA values were recorded from routinely collected serum/blood samples of the patients. The relationship between tumor biomarkers and patients diagnosed with childhood cancers was evaluated.</p></div><div><h3>Results</h3><p>The study included 211 patients. Out of 211 patients, 145 (68.7%) were female, and 66 (31.3%) were male. Malignancy was detected in 35 patients (16.6%). There was no statistically significant relationship observed between CA 15-3, CA 19-9, and CEA positivity and the detection of malignancy. The respective p-values were found to be (p=0.711, p= 0.533, p=0.573). A statistically significant relationship was observed between CA-125 positivity and the detection of malignancy (p=0.002).</p></div><div><h3>Conclusion</h3><p>Tumor markers alone are not sufficient for making a definitive diagnosis or determining treatment decisions. However further comprehensive studies are needed for detection of association conventional tumor markers and childhood cancers.</p></div>\",\"PeriodicalId\":12958,\"journal\":{\"name\":\"Hematology, Transfusion and Cell Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2531137924001251/pdfft?md5=78cb5f38388d222e37665dba01ff65ef&pid=1-s2.0-S2531137924001251-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematology, Transfusion and Cell Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2531137924001251\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, Transfusion and Cell Therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2531137924001251","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的 我们旨在调查儿童较少使用的碳水化合物抗原 19-9 (CA19-9)、碳水化合物抗原 125 (CA-125)、碳水化合物抗原 15-3 (CA15-3) 和癌胚抗原 (CEA) 肿瘤生物标志物的适应症及其与确诊儿童癌症患者的关联。方法该研究旨在纳入2022年11月1日至2023年11月1日期间在阿达纳市培训与研究医院(ACTRH)接受CA 19-9、CA-125、CA 15-3和CEA肿瘤生物标志物评估的0-18岁患者。CA 19-9、CA-125、CA 15-3和CEA的值记录自患者常规采集的血清/血液样本。研究评估了肿瘤生物标志物与儿童癌症患者之间的关系。在211名患者中,145名(68.7%)为女性,66名(31.3%)为男性。35名患者(16.6%)发现了恶性肿瘤。CA 15-3、CA 19-9和CEA阳性与恶性肿瘤的检出率之间没有统计学意义上的显著关系。P值分别为(P=0.711、P= 0.533、P=0.573)。CA-125阳性与恶性肿瘤的检出之间有统计学意义(P=0.002)。然而,要检测常规肿瘤标志物与儿童癌症之间的关系,还需要进一步的综合研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
EVALUATION OF THE ASSOCIATION OF TUMOR BIOMARKERS WITH CHILDHOOD CANCERS

Objective

We aimed to investigate the indications for Carbohydrate antigen 19-9 (CA 19-9), carbohydrate antigen 125 (CA-125), carbohydrate antigen 15-3 (CA15-3) and carcinoembryogenic antigen (CEA) tumor biomarkers, less commonly used in children, and their association with patients diagnosed with childhood cancers.

Methodology

The study aimed to include patients aged 0-18 who had CA 19-9, CA-125, CA 15-3 and CEA tumor biomarker assessments at Adana City Training and Research Hospital (ACTRH) between 01.11.2022 and 01.11.2023. CA 19-9, CA-125, CA 15-3 and CEA values were recorded from routinely collected serum/blood samples of the patients. The relationship between tumor biomarkers and patients diagnosed with childhood cancers was evaluated.

Results

The study included 211 patients. Out of 211 patients, 145 (68.7%) were female, and 66 (31.3%) were male. Malignancy was detected in 35 patients (16.6%). There was no statistically significant relationship observed between CA 15-3, CA 19-9, and CEA positivity and the detection of malignancy. The respective p-values were found to be (p=0.711, p= 0.533, p=0.573). A statistically significant relationship was observed between CA-125 positivity and the detection of malignancy (p=0.002).

Conclusion

Tumor markers alone are not sufficient for making a definitive diagnosis or determining treatment decisions. However further comprehensive studies are needed for detection of association conventional tumor markers and childhood cancers.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.40
自引率
4.80%
发文量
1419
审稿时长
30 weeks
期刊最新文献
PRELIMINARY RESULTS FROM A MULTICENTER PHASE 2/3 STUDY OF NEXT-GENERATION SICKLE HEMOGLOBIN POLYMERIZATION INHIBITOR OSIVELOTOR (GBT021601) FOR THE TREATMENT OF PATIENTS WITH SICKLE CELL DISEASE DOENÇA HEMOLÍTICA DO FETO E DO RECÉM-NASCIDO POR ALOIMUNIZAÇÃO RH - INQUIRIÇÃO NARRATIVA OFICINA DA MEMÓRIA:PROPOSTA DE REABILITAÇÃO COGNITIVA EM PACIENTES QUE VIVEM COM DOENÇA FALCIFORME LASERTERAPIA NO TRATAMENTO COADJUVANTE DA DOR DA NECROSE ASSÉPTICA DA CABEÇA DO FÉMUR NA DOENÇA FALCIFORME; RELATOS DE CASO ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1